Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALZN | Common Stock | Options Exercise | $0 | +47.2K | +1699.86% | $0.00 | 50K | Oct 15, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALZN | Restricted Stock Grant | Options Exercise | $0 | -47.2K | -48.57% | $0.00 | 50K | Oct 15, 2021 | Common Stock | 47.2K | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Represents the vesting of restricted stock |
F2 | Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc. |
F3 | The restricted stock grant was amended on October 13, 2021, such that 47,222 shares of restricted stock vested on October 15, 2021, and the remaining 50,000 shares of restricted stock shall vest on March 15, 2022. 2,778 shares previously vested on September 13, 2021. |